SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-019194
Filing Date
2023-11-17
Accepted
2023-11-17 16:10:23
Documents
12
Period of Report
2023-11-13
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K aytu-20231113x8k.htm   iXBRL 8-K 35763
  Complete submission text file 0001558370-23-019194.txt   156103

Data Files

Seq Description Document Type Size
2 EX-101.SCH aytu-20231113.xsd EX-101.SCH 3132
3 EX-101.LAB aytu-20231113_lab.xml EX-101.LAB 15904
4 EX-101.PRE aytu-20231113_pre.xml EX-101.PRE 10061
6 EXTRACTED XBRL INSTANCE DOCUMENT aytu-20231113x8k_htm.xml XML 4905
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 231418750
SIC: 2834 Pharmaceutical Preparations